No­var­tis will change CRO re­la­tion­ships ‘over time’ as Sen­ate bill tar­get­ing Chi­nese com­pa­nies looms

No­var­tis is “ac­tive­ly” man­ag­ing its ex­ist­ing re­la­tion­ships with Chi­nese ser­vice providers to mit­i­gate risks if the Biose­cure Act pass­es.

CFO Har­ry Kirsch told me­dia on …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER